Back to state act
Description
The EIB's loan for the amount of EUR 25 million (approx. USD 30.3 million) loan with OSE Immunotherapeutics, signed on 12 February 2021, formed part of the EIB’s strategy to support biotech companies ...
Sign in to see full description
Intervention Details
Intervention Type
Loan guarantee
MAST Chapter
L: Subsidies (excl. export subsidies)
Implementation date
12 Feb 2021
Revocation date
No revocation date
Implementation level
Supranational
Affected flow
Inward
Announced as temporary
No
Eligible firms
firm-specific
Affected Trading Partners
Table
Affected Sectors
Sign in to access 1 sectors
Affected Products
Sign in to access 15 products
Threads
See all
This intervention is not part of any Thread yet.